D. Boral Capital LLC acted as the exclusive placement agent for the offering. Ortoli Rosenstadt LLP acted as counsel to the ...
FAVO Capital, Inc. (OTC PINK:FAVO), a leading provider of alternative financing solutions in the Private Credit Sector, today ...
FAVO Capital, Inc. (OTC PINK:FAVO), a leading provider of alternative financing solutions in the Private Credit Sector, today announced that it has entered into securities purchase agreements with ...
Fintel reports that on December 10, 2024, D. Boral Capital downgraded their outlook for CervoMed (NasdaqCM:CRVO) from Buy to ...
D. Boral Capital argues that Biomea Fusion’s (BMEA) presentations at the 22nd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease “highlight icovamenib’s groundbreaking potential ...
D. Boral Capital analyst Jason Kolbert says investors should “stay the course” on Carisma Therapeutics (CARM) amid the rating downgrades ...
As a CEO, issues and decisions come to the table multiple times every day. You need to decide on which issues to intervene, ...
Building materials company Boral reckons its upgraded Southern Highlands-based Berrima Cement Works in New South Wales will ...
D. Boral Capital is acting as the exclusive placement agent for the offering. The securities were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended ...